Prev

Why Respiratory Disease Deaths Are Dropping—But Cases Keep Rising

Next

A major global study reveals a surprising twist: while fewer people are dying from chronic lung diseases, more people are getting them. Here's what's changing.

Here's something that might surprise you: even though more people around the world are developing chronic respiratory diseases, fewer of them are dying from these conditions. That's the counterintuitive finding from a massive new analysis of global respiratory health trends spanning three decades.

The Big Picture: More Cases, Fewer Deaths

In 2023 alone, chronic respiratory diseases—including COPD, asthma, and lung scarring conditions—affected 569.2 million people worldwide and caused 4.2 million deaths. But here's the encouraging part: the global death rate from these diseases has dropped by 25.7% since 1990, even as the number of people diagnosed continues to climb.

This improvement is a win for modern medicine and public health efforts. Better treatments, earlier detection, and improved access to care are all playing a role in helping people live longer with these conditions.

Who's Being Hit Hardest?

The story isn't the same for everyone, though. Younger men have seen particularly strong improvements in asthma survival rates. But older adults are facing a tougher picture: they're experiencing rising rates of interstitial lung disease (a scarring condition that makes breathing harder) and pulmonary sarcoidosis (an inflammatory disease affecting the lungs).

This age divide suggests that while we're getting better at managing common respiratory problems in younger people, we still have work to do when it comes to the more complex lung conditions that develop later in life.

What's Causing These Diseases?

The research also pinpointed the main culprits behind different respiratory conditions. Smoking remains the leading cause of COPD—a disease that makes breathing progressively harder over time. For asthma, high body mass index emerged as a key risk factor, while silica exposure (often from workplace environments) is a major driver of pneumoconiosis, a type of occupational lung disease.

The COVID-19 Effect

Interestingly, during the COVID-19 pandemic, the number of new chronic respiratory disease cases increased only modestly, but the decline in death rates actually became more pronounced. This suggests that pandemic-era improvements in respiratory care and awareness may have had some unexpected benefits for people managing chronic lung conditions.

What This Means for You

The takeaway? Chronic respiratory diseases remain a serious global health challenge affecting hundreds of millions of people. But the trend toward lower death rates shows that progress is possible. If you smoke, quitting remains one of the most powerful steps you can take to protect your lungs. And if you're experiencing breathing difficulties, modern treatments are more effective than ever—so it's worth talking to your doctor.

More from Respiratory Health